|
1
|
Miller AJ and Mihm MC Jr: Melanoma. N Engl
J Med. 355:51–65. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eggermont AM, Suciu S, Rutkowski P, Kruit
WH, Punt CJ, Dummer R, Salès F, Keilholz U, de Schaetzen G and
Testori A; EORTC Melanoma Group, : Long term follow up of the EORTC
18952 trial of adjuvant therapy in resected stage IIB-III cutaneous
melanoma patients comparing intermediate doses of
interferon-alpha-2b (IFN) with observation: Ulceration of primary
is key determinant for IFN-sensitivity. Eur J Cancer. 55:111–121.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pacheco I, Buzea C and Tron V: Towards new
therapeutic approaches for malignant melanoma. Expert Rev Mol Med.
13:e332011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fang W, Fan Y, Fa Z, Xu J, Yu H, Li P and
Gu J: microRNA-625 inhibits tumorigenicity by suppressing
proliferation, migration and invasion in malignant melanoma.
Oncotarget. 8:13253–13263. 2017.PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Adams BD, Parsons C, Walker L, Zhang WC
and Slack FJ: Targeting noncoding RNAs in disease. J Clin Invest.
127:761–771. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li S, Xu X, Xu X, Hu Z, Wu J, Zhu Y, Chen
H, Mao Y, Lin Y, Luo J, et al: MicroRNA-490-5p inhibits
proliferation of bladder cancer by targeting c-Fos. Biochem Biophys
Res Commun. 441:976–981. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang J, Wu W, Xu S, Zhang J, Zhang J, Yu
Q, Jiao Y, Wang Y, Lu A, You Y, et al: MicroRNA-105 inhibits human
glioma cell malignancy by directly targeting SUZ12. Tumour Biol.
39:10104283177057662017.PubMed/NCBI
|
|
16
|
Asahchop EL, Akinwumi SM, Branton WG,
Fujiwara E, Gill MJ and Power C: Plasma microRNA profiling predicts
HIV-associated neurocognitive disorder. AIDS. 30:2021–2031. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang W, Zhang H, Tang M, Liu L, Zhou Z,
Zhang S and Wang L: MicroRNA-592 targets IGF-1R to suppress
cellular proliferation, migration and invasion in hepatocellular
carcinoma. Oncol Lett. 13:3522–3528. 2017.PubMed/NCBI
|
|
18
|
Zhang P, Kong F, Deng X, Yu Y, Hou C,
Liang T and Zhu L: MicroRNA-326 suppresses the proliferation,
migration and invasion of cervical cancer cells by targeting ELK1.
Oncol Lett. 13:2949–2956. 2017.PubMed/NCBI
|
|
19
|
Liang Z, Wang X, Xu X, Xie B, Ji A, Meng
S, Li S, Zhu Y, Wu J, Hu Z, et al: MicroRNA-608 inhibits
proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
Mol Cancer. 16:962017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhai LL, Wang P, Zhou LY, Yin JY, Tang Q,
Zhang TJ, Wang YX, Yang DQ, Lin J and Deng ZQ: Over-expression of
miR-675 in formalin-fixed paraffin-embedded (FFPE) tissues of
breast cancer patients. Int J Clin Exp Med. 8:11195–11201.
2015.PubMed/NCBI
|
|
21
|
Vennin C, Spruyt N, Dahmani F, Julien S,
Bertucci F, Finetti P, Chassat T, Bourette RP, Le Bourhis X and
Adriaenssens E: H19 non coding RNA-derived miR-675 enhances
tumorigenesis and metastasis of breast cancer cells by
downregulating c-Cbl and Cbl-b. Oncotarget. 6:29209–29223. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu C, Chen Z, Fang J, Xu A, Zhang W and
Wang Z: H19-derived miR-675contributes to bladder cancer cell
proliferation by regulating p53 activation. Tumour Biol.
37:263–270. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky
DJ and Fisher PB: Cloning and characterization of HIV-1-inducible
astrocyte elevated gene-1, AEG-1. Gene. 353:8–15. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang Y and Li LP: Progress of cancer
research on astrocyte elevated gene-1/Metadherin (Review). Oncol
Lett. 8:493–501. 2014.PubMed/NCBI
|
|
26
|
Zhang Y, Peng G, Wang Y, Cui L, Wu W, Wang
L, Liu C and Han X: Silencing of astrocyte elevated gene-1 inhibits
proliferation and migration of melanoma cells and induces
apoptosis. Clin Exp Pharmacol Physiol. 44:815–826. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bustos MA, Ono S, Marzese DM, Oyama T,
Iida Y, Cheung G, Nelson N, Hsu SC, Yu Q and Hoon DSB: miR-200a
regulates CDK4/6 Inhibitor effect by targeting CDK6 in metastatic
melanoma. J Invest Dermatol. 137:1955–1964. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He J, Tian N, Yang Y, Jin L, Feng X, Hua
J, Lin S, Wang B, Li H and Wang J: miR-185 enhances the inhibition
of proliferation and migration induced by ionizing radiation in
melanoma. Oncol Lett. 13:2442–2448. 2017.PubMed/NCBI
|
|
29
|
Zeng HF, Yan S and Wu SF: MicroRNA-153-3p
suppress cell proliferation and invasion by targeting SNAI1 in
melanoma. Biochem Biophys Res Commun. 487:140–145. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guan GF, Zhang DJ, Wen LJ, Xin D, Liu Y,
Yu DJ, Su K, Zhu L, Guo YY and Wang K: Overexpression of lncRNA
H19/miR-675 promotes tumorigenesis in head and neck squamous cell
carcinoma. Int J Med Sci. 13:914–922. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu YQ, Weng J, Li SQ, Li B and Lv J:
miR-675 promotes the growth of hepatocellular carcinoma cells
through the Cdc25A pathway. Asian Pac J Cancer Prev. 17:3881–3885.
2016.PubMed/NCBI
|
|
32
|
Lv J, Ma L, Chen XL, Huang XH and Wang Q:
Downregulation of LncRNAH19 and miR-675 promotes migration and
invasion of human hepatocellular carcinoma cells through
AKT/GSK-3β/Cdc25A signaling pathway. J Huazhong Univ Sci Technolog
Med Sci. 34:363–369. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
He D, Wang J, Zhang C, Shan B, Deng X, Li
B, Zhou Y, Chen W, Hong J, Gao Y, et al: Down-regulation of
miR-675-5p contributes to tumor progression and development by
targeting pro-tumorigenic GPR55 in non-small cell lung cancer. Mol
Cancer. 14:732015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Zhang Y, Wei H, Zhang X, Wu Y,
Gong A, Xia Y, Wang W and Xu M: The mir-675-5p regulates the
progression and development of pancreatic cancer via the
UBQLN1-ZEB1-mir200 axis. Oncotarget. 8:24978–24987. 2017.PubMed/NCBI
|
|
35
|
Schmitz KJ, Helwig J, Bertram S, Sheu SY,
Suttorp AC, Seggewiss J, Willscher E, Walz MK, Worm K and Schmid
KW: Differential expression of microRNA-675, microRNA-139-3p and
microRNA-335 in benign and malignant adrenocortical tumours. J Clin
Pathol. 64:529–535. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng
R, Wang Y, Huang J, Xu M, Yan J and Yu J: lncRNA H19/miR-675 axis
represses prostate cancer metastasis by targeting TGFBI. FEBS J.
281:3766–3775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li C, Lei B, Huang S, Zheng M, Liu Z, Li Z
and Deng Y: H19 derived microRNA-675 regulates cell proliferation
and migration through CDK6 in glioma. Am J Transl Res. 7:1747–1764.
2015.PubMed/NCBI
|
|
38
|
Yao J, Zhang P, Li J and Xu W:
MicroRNA-215 acts as a tumor suppressor in breast cancer by
targeting AKT serine/threonine kinase 1. Oncol Lett. 14:1097–1104.
2017.PubMed/NCBI
|
|
39
|
Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao
W, Volsky DJ and Fisher PB: Identification and cloning of human
astrocyte genes displaying elevated expression after infection with
HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid
subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gnosa S, Shen YM, Wang CJ, Zhang H,
Stratmann J, Arbman G and Sun XF: Expression of AEG-1 mRNA and
protein in colorectal cancer patients and colon cancer cell lines.
J Transl Med. 10:1092012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li J, Zhang N, Song LB, Liao WT, Jiang LL,
Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS and Li M: Astrocyte
elevated gene-1 is a novel prognostic marker for breast cancer
progression and overall patient survival. Clin Cancer Res.
14:3319–3326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yu JQ, Zhou Q, Zhu H, Zheng FY and Chen
ZW: Overexpression of astrocyte elevated gene-1 (AEG-1) in cervical
cancer and its correlation with angiogenesis. Asian Pac J Cancer
Prev. 16:2277–2281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dong L, Qin S, Li Y, Zhao L, Dong S, Wang
Y, Zhang C and Han S: High expression of astrocyte elevated gene-1
is associated with clinical staging, metastasis and unfavorable
prognosis in gastric carcinoma. Tumour Biol. 36:2169–2178. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang G, Zhang L, Lin S, Li L, Liu M, Chen
H, Cao M, Liu D, Huang YR and Bo J: AEG-1 is associated with tumor
progression in nonmuscle-invasive bladder cancer. Med Oncol.
31:9862014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hu G, Wei Y and Kang Y: The multifaceted
role of MTDH/AEG-1 in cancer progression. Clin Cancer Res.
15:5615–5620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Emdad L, Lee SG, Su ZZ, Jeon HY, Boukerche
H, Sarkar D and Fisher PB: Astrocyte elevated gene-1 (AEG-1)
functions as an oncogene and regulates angiogenesis. Proc Natl Acad
Sci USA. 106:pp. 21300–21305. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Du Y, Jiang B, Song S, Pei G, Ni X, Wu J,
Wang S, Wang Z and Yu J: Metadherin regulates actin cytoskeletal
remodeling and enhances human gastric cancer metastasis via
epithelial-mesenchymal transition. Int J Oncol. 51:63–74. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zou B and Wang S: Expression and
prognostic value of MTDH, Bcl-2 and E-cadherin in sinonasal
malignant mucosal melanoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke
Za Zhi. 50:1009–1014. 2015.(In Chinese). PubMed/NCBI
|
